J-Pharma Co., Ltd.
520AGrowth MarketPharmaceuticals
2nd Quarter of FY2027/3Executive Interview
Japan/Korea Expansion and AMED Grant Selection Elevate the Global Development Value of Nanvuranlat
October 15, 2026 at 14:00 GMT+9
J-Pharma Co., Ltd.
520A・Growth Market・Pharmaceuticals
J-Pharma Co., Ltd.520A